Copyright © 2011 TP. Velavan and Olusola Ojurongbe. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. R. M. Maizels, “Parasite immunomodulation and polymorphisms of the immune system,” Journal of Biology, vol. 8, no. 7, article 62, 2009. View at Publisher · View at Google Scholar · View at PubMed
2. P. Schmid-Hempel, “Parasite immune evasion: a momentous molecular war,” Trends in Ecology and Evolution, vol. 23, no. 6, pp. 318–326, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. Y. Belkaid, R. B. Blank, and I. Suffia, “Natural regulatory T cells and parasites: a common quest for host homeostasis,” Immunological Reviews, vol. 212, pp. 287–300, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. T. P. Velavan, S. Bechlars, J. Tomiuk, P. G. Kremsner, and J. F.J. Kun, “Molecular characterization of regulatory polymorphisms in the promoter region of the STAT6 gene in a gabonese population,” Memorias do Instituto Oswaldo Cruz, vol. 106, no. 1, pp. 65–69, 2011.
5. S. Sakaguchi, “Regulatory T cells: key controllers of immunologic self-tolerance,” Cell, vol. 101, no. 5, pp. 455–458, 2000. View at Scopus
6. S. Sakaguchi, “Naturally arising CD4⁺ regulatory T cells for immunologic self-tolerance and negative control of immune responses,” Annual Review of Immunology, vol. 22, pp. 531–562, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
7. S. Sakaguchi, R. Setoguchi, H. Yagi, and T. Nomura, “Naturally arising Foxp3-expressing CD25(+)CD4(+) regulatory T cells in self-tolerance and autoimmune disease,” Current Concepts in Autoimmunity and Chronic Inflamation, vol. 305, pp. 51–66, 2006.
8. M. Miyara and S. Sakaguchi, “Natural regulatory T cells: mechanisms of suppression,” Trends in Molecular Medicine, vol. 13, no. 3, pp. 108–116, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
9. Y. Belkaid, “Regulatory T cells and infection: a dangerous necessity,” Nature Reviews Immunology, vol. 7, no. 11, pp. 875–888, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. S. A. Hanel, V. Tp, P. G. Kremsner, and J. F.J. Kun, “Novel and functional regulatory SNPs in the promoter region of FOXP3 gene in a Gabonese population,” Immunogenetics, vol. 63, no. 7, pp. 409–415, 2011. View at Publisher · View at Google Scholar · View at PubMed
11. J. C. Lee, E. Hayman, H. J. Pegram et al., “In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy,” Cancer Research, vol. 71, no. 8, pp. 2871–2881, 2011. View at Publisher · View at Google Scholar · View at PubMed
12. J. E. Mold, J. Michaëlsson, T. D. Burt et al., “Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero,” Science, vol. 322, no. 5907, pp. 1562–1565, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. H. von Boehmer, “Mechanisms of suppression by suppressor T cells,” Nature Immunology, vol. 6, no. 4, pp. 338–344, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. D. A. Horwitz, S. G. Zheng, and J. D. Gray, “Natural and TGF-β-induced Foxp3⁺CD4⁺ CD25⁺ regulatory T cells are not mirror images of each other,” Trends in Immunology, vol. 29, no. 9, pp. 429–435, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. R. Bacchetta, E. Gambineri, and M. G. Roncarolo, “Role of regulatory T cells and FOXP3 in human diseases,” Journal of Allergy and Clinical Immunology, vol. 120, no. 2, pp. 227–235, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
16. J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, “Foxp3 programs the development and function of CD4⁺CD25⁺ regulatory T cells,” Nature Immunology, vol. 4, no. 4, pp. 330–336, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
17. R. Haque, F. Lei, X. Xiong, and J. Song, “The regulation of FoxP3-expressing regulatory T cells,” Endocrine, Metabolic & Immune Disorders—Drug Targets. In press.
18. Y. Belkaid and K. Tarbell, “Regulatory T cells in the control of host-microorganism interactions,” Annual Review of Immunology, vol. 27, pp. 551–589, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. N. Cools, P. Ponsaerts, V. F. I. Van Tendeloo, and Z. N. Berneman, “Regulatory T cells and human disease,” Clinical and Developmental Immunology, vol. 2007, Article ID 89195, 2007. View at Publisher · View at Google Scholar · View at PubMed
20. S. Paust, L. Lu, N. McCarty, and H. Cantor, “Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 28, pp. 10398–10403, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
21. S. Sakaguchi, N. Sakaguchi, J. Shimizu et al., “Immunologic tolerance maintained by CD25⁺ CD4⁺ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance,” Immunological Reviews, vol. 182, pp. 18–32, 2001. View at Publisher · View at Google Scholar · View at Scopus
22. K. J. Maloy, L. Salaun, R. Cahill, G. Dougan, N. J. Saunders, and F. Powrie, “CD4⁺CD25⁺ TR cells suppress innate immune pathology through cytokine-dependent mechanisms,” Journal of Experimental Medicine, vol. 197, no. 1, pp. 111–119, 2003. View at Publisher · View at Google Scholar · View at Scopus
23. A. L. Mellor and D. H. Munn, “IDO expression by dendritic cells: tolerance and tryptophan catabolism,” Nature Reviews Immunology, vol. 4, no. 10, pp. 762–774, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. D. H. Munn, M. D. Sharma, J. R. Lee et al., “Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase,” Science, vol. 297, no. 5588, pp. 1867–1870, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. W. J. Grossman, J. W. Verbsky, B. L. Tollefsen, C. Kemper, J. P. Atkinson, and T. J. Ley, “Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells,” Blood, vol. 104, no. 9, pp. 2840–2848, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
26. W. J. Grossman, J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson, and T. J. Ley, “Human T regulatory cells can use the perforin pathway to cause autologous target cell death,” Immunity, vol. 21, no. 4, pp. 589–601, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. A. Taylor, J. Verhagen, K. Blaser, M. Akdis, and C. A. Akdis, “Mechanisms of immune suppression by interleukin-10 and transforming growth factor-β: the role of T regulatory cells,” Immunology, vol. 117, no. 4, pp. 433–442, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. M. K. Levings, R. Bacchetta, U. Schulz, and M. G. Roncarolo, “The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells,” International archives of allergy and immunology, vol. 129, no. 4, pp. 263–276, 2002. View at Scopus
29. M. L. Chen, M. J. Pittet, L. Gorelik et al., “Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 2, pp. 419–424, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
30. K. W. Moore, R. D. Malefyt, R. L. Coffman, and A. O'Garra, “Interleukin-10 and the interleukin-10 receptor,” Annual Review of Immunology, vol. 19, pp. 683–765, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. H. Strobl and W. Knapp, “TGF-β1 regulation of dendritic cells,” Microbes and Infection, vol. 1, no. 15, pp. 1283–1290, 1999. View at Publisher · View at Google Scholar · View at Scopus
32. J. R. Grainger, K. A. Smith, J. P. Hewitson et al., “Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway,” Journal of Experimental Medicine, vol. 207, no. 11, pp. 2331–2341, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. M. Montes, C. Sanchez, K. Verdonck et al., “Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen,” PLoS Neglected Tropical Diseases, vol. 3, no. 6, article e456, 2009. View at Publisher · View at Google Scholar · View at PubMed
34. R. M. Maizels and M. Yazdanbakhsh, “Immune regulation by helminth parasites: cellular and molecular mechanisms,” Nature Reviews Immunology, vol. 3, no. 9, pp. 733–744, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. K. Brustoski, U. Möller, M. Kramer et al., “Reduced cord blood immune effector-cell responsiveness mediated by CD4 ⁺ cells induced in utero as a consequence of placental Plasmodium falciparum infection,” Journal of Infectious Diseases, vol. 193, no. 1, pp. 146–154, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. A. M. Vigário, O. Gorgette, H. C. Dujardin et al., “Regulatory CD4⁺CD25⁺ Foxp3⁺ T cells expand during experimental Plasmodium infection but do not prevent cerebral malaria,” International Journal for Parasitology, vol. 37, no. 8-9, pp. 963–973, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
37. F. H. Amante, A. C. Stanley, L. M. Randall et al., “A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria,” American Journal of Pathology, vol. 171, no. 2, pp. 548–559, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. C. Q. Nie, N. J. Bernard, L. Schofield, and D. S. Hansen, “CD4⁺ CD25⁺ regulatory T cells suppress CD4 ⁺ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis,” Infection and Immunity, vol. 75, no. 5, pp. 2275–2282, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
39. G. Minigo, T. Woodberry, K. A. Piera et al., “Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria,” PLoS Pathogens, vol. 5, no. 4, Article ID e1000402, 2009. View at Publisher · View at Google Scholar · View at PubMed
40. S. M. Todryk, P. Bejon, T. Mwangi et al., “Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4⁺ CD25high T cells with susceptibility in Kenyans,” PLoS ONE, vol. 3, no. 4, Article ID e2027, 2008. View at Publisher · View at Google Scholar · View at PubMed
41. M. Walther, J. E. Tongren, L. Andrews et al., “Upregulation of TGF-β, FOXP3, and CD4⁺CD25⁺ regulatory T cells correlates with more rapid parasite growth in human malaria infection,” Immunity, vol. 23, no. 3, pp. 287–296, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
42. L. L. Bueno, C. G. Morais, F. F. Araújo et al., “Plasmodium vivax: induction of CD4⁺CD25⁺FoxP3 ⁺ regulatory T cells during infection are directly associated with level of circulating parasites,” PLoS ONE, vol. 5, no. 3, Article ID e9623, 2010. View at Publisher · View at Google Scholar · View at PubMed
43. Y. Wu, Q. H. Wang, L. Zheng et al., “Plasmodium yoelii: distinct CD4⁺CD25⁺ regulatory T cell responses during the early stages of infection in susceptible and resistant mice,” Experimental Parasitology, vol. 115, no. 3, pp. 301–304, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
44. J. Satoguina, M. Mempel, J. Larbi et al., “Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis),” Microbes and Infection, vol. 4, no. 13, pp. 1291–1300, 2002. View at Publisher · View at Google Scholar · View at Scopus
45. W. H. Hoffmann, A. W. Pfaff, H. Schulz-Key, and P. T. Soboslav, “Determinants for resistance and susceptibility to microfilaraemia in Litomosoides sigmodontis filariasis,” Parasitology, vol. 122, no. 6, pp. 641–649, 2001. View at Publisher · View at Google Scholar · View at Scopus
46. P. T. Soboslay, C. M. Dreweck, H. R. Taylor, B. Brotman, P. Wenk, and B. M. Greene, “Experimental onchocerciasis in chimpanzees: cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection,” Journal of Immunology, vol. 147, no. 1, pp. 346–353, 1991. View at Scopus
47. J. C. Marie, J. J. Letterio, M. Gavin, and A. Y. Rudensky, “TGF-β1 maintains suppressor function and Foxp3 expression in CD4 ⁺CD25⁺ regulatory T cells,” Journal of Experimental Medicine, vol. 201, no. 7, pp. 1061–1067, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
48. M. G. Roncarolo, S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings, “Interleukin-10-secreting type 1 regulatory T cells in rodents and humans,” Immunological Reviews, vol. 212, pp. 28–50, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
49. M. D. Taylor, N. van der Werf, A. Harris et al., “Early recruitment of natural CD4⁺Foxp3⁺ Treg cells by infective larvae determines the outcome of filarial infection,” European Journal of Immunology, vol. 39, no. 1, pp. 192–206, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
50. H. J. McSorley, Y. M. Harcus, J. Murray, M. D. Taylor, and R. M. Maizels, “Expansion of Foxp3⁺ regulatory T cells in mice infected with the filarial parasite Brugia malayi,” Journal of Immunology, vol. 181, no. 9, pp. 6456–6466, 2008. View at Scopus
51. C. A. M. Finney, M. D. Taylor, M. S. Wilson, and R. M. Maizels, “Expansion and activation of CD4⁺CD25⁺ regulatory T cells in Heligmosomoides polygyrus infection,” European Journal of Immunology, vol. 37, no. 7, pp. 1874–1886, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
52. M. S. Wilson, M. D. Taylor, A. Balic, C. A. M. Finney, J. R. Lamb, and R. M. Maizels, “Suppression of allergic airway inflammation by helminth-induced regulatory T cells,” Journal of Experimental Medicine, vol. 202, no. 9, pp. 1199–1212, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
53. D. P. Beiting, L. F. Gagliardo, M. Hesse, S. K. Bliss, D. Meskill, and J. A. Appleton, “Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-β,” Journal of Immunology, vol. 178, no. 2, pp. 1039–1047, 2007. View at Scopus
54. F. S. Mariano, F. R. S. Gutierrez, W. R. Pavanelli et al., “The involvement of CD4⁺CD25⁺ T cells in the acute phase of Trypanosoma cruzi infection,” Microbes and Infection, vol. 10, no. 7, pp. 825–833, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
55. F. F. de Araújo, D. M. Vitelli-Avelar, A. Teixeira-Carvalho et al., “Regulatory T cells phenotype in different clinical forms of chagas' disease,” PLoS Neglected Tropical Diseases, vol. 5, no. 5, 2011. View at Publisher · View at Google Scholar · View at PubMed
56. K. W. Schleifer and J. M. Mansfield, “Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins,” Journal of Immunology, vol. 151, no. 10, pp. 5492–5503, 1993. View at Scopus
57. M. Guilliams, G. Oldenhove, W. Noel et al., “African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation,” Journal of Immunology, vol. 179, no. 5, pp. 2748–2757, 2007. View at Scopus
58. J. G. Montoya, H. B. Huffman, and J. S. Remington, “Evaluation of the immunoglobulin G avidity test for diagnosis of toxoplasmic lymphadenopathy,” Journal of Clinical Microbiology, vol. 42, no. 10, pp. 4627–4631, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
59. E. Y. Denkers and R. T. Gazzinelli, “Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection,” Clinical Microbiology Reviews, vol. 11, no. 4, pp. 569–588, 1998. View at Scopus
60. E. P. Tenorio, J. E. Olguín, J. Fernández, P. Vieyra, and R. Saavedra, “Reduction of Foxp3⁺ cells by depletion with the PC61 mAb induces mortality in resistant BALB/c mice infected with Toxoplasma gondii,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 786078, 2010.
61. R. M. Maizels, D. A. P. Bundy, M. E. Selkirk, D. F. Smith, and R. M. Anderson, “Immunological modulation and evasion by helminth parasites in human populations,” Nature, vol. 365, no. 6449, pp. 797–805, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
62. Y. Belkaid, “Role of Foxp3-positive regulatory T cells during infection,” European Journal of Immunology, vol. 38, no. 4, pp. 918–921, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
63. T. A. Wynn, A. W. Cheever, M. E. Williams et al., “IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease,” Journal of Immunology, vol. 160, no. 9, pp. 4473–4480, 1998. View at Scopus
64. M. Niikura, S. Kamiya, A. Nakane, K. Kita, and F. Kobayashi, “IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites,” International Journal for Parasitology, vol. 40, no. 1, pp. 101–108, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
65. S. Specht, D. F. Ruiz, B. Dubben, S. Deininger, and A. Hoerauf, “Filaria-induced IL-10 suppresses murine cerebral malaria,” Microbes and Infection, vol. 12, no. 8-9, pp. 635–642, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
66. S. Mahanty, S. N. Mollis, M. Ravichandran et al., “High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis,” Journal of Infectious Diseases, vol. 173, no. 3, pp. 769–773, 1996. View at Scopus
67. M. Baumgart, F. Tompkins, J. Leng, and M. Hesse, “Naturally occurring CD4⁺Foxp3⁺ regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation,” Journal of Immunology, vol. 176, no. 9, pp. 5374–5387, 2006. View at Scopus
68. J. J. Taylor, M. Mohrs, and E. J. Pearce, “Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population,” Journal of Immunology, vol. 176, no. 10, pp. 5839–5847, 2006. View at Scopus
69. K. P. Singh, H. C. Gerard, A. P. Hudson, T. R. Reddy, and D. L. Boros, “Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice,” Immunology, vol. 114, no. 3, pp. 410–417, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
70. K. Watanabe, P. N. M. Mwinzi, C. L. Black et al., “T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment,” American Journal of Tropical Medicine and Hygiene, vol. 77, no. 4, pp. 676–682, 2007. View at Scopus
71. P. Zaccone, O. Burton, N. Miller, F. M. Jones, D. W. Dunne, and A. Cooke, “Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice,” European Journal of Immunology, vol. 39, no. 4, pp. 1098–1107, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
72. X. Wang, S. Zhou, Y. Chi et al., “CD4⁺CD25⁺ Treg induction by an HSP60-derived peptide SJMHE1 from Schistosoma japonicum is TLR2 dependent,” European Journal of Immunology, vol. 39, no. 11, pp. 3052–3065, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
73. R. M. Anthony, L. I. Rutitzky, J. F. Urban Jr., M. J. Stadecker, and W. C. Gause, “Protective immune mechanisms in helminth infection,” Nature Reviews Immunology, vol. 7, no. 12, pp. 975–987, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
74. R. Maurya, R. Kumar, V. K. Prajapati et al., “Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3⁺ CD4 cells in blood or spleen,” Parasite Immunology, vol. 32, no. 7, pp. 479–483, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
75. S. Mendez, S. K. Reckling, C. A. Piccirillo, D. Sacks, and Y. Belkaid, “Role for CD4⁺ CD25⁺ regulatory T cells in reactivation of persistent Leishmaniasis and control of concomitant immunity,” Journal of Experimental Medicine, vol. 200, no. 2, pp. 201–210, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
76. P. C. Melby, Y. Z. Yang, J. Cheng, and W. Zhao, “Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani,” Infection and Immunity, vol. 66, no. 1, pp. 18–27, 1998. View at Scopus
77. L. Nicolas, S. Sidjanski, J. H. Colle, and G. Milon, “Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice,” Infection and Immunity, vol. 68, no. 12, pp. 6561–6566, 2000. View at Publisher · View at Google Scholar · View at Scopus
78. T. Aebischer and E. Handman, “Influence of the route of vaccination on antigen presentation and T-cell mediated lymphokine response in murine cutaneous leishmaniasis,” Journal of Cellular Biochemistry, vol. 64, 1993.
79. T. Aebischer, S. F. Moody, and E. Handman, “Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host,” Infection and Immunity, vol. 61, no. 1, pp. 220–226, 1993. View at Scopus
80. Y. Belkaid, K. F. Hoffmann, S. Mendez et al., “The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure,” Journal of Experimental Medicine, vol. 194, no. 10, pp. 1497–1506, 2001. View at Publisher · View at Google Scholar · View at Scopus
81. K. Yamakami, S. Akao, T. Tadakuma, Y. Nitta, J. I. Miyazaki, and N. Yoshizawa, “Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major,” Immunology, vol. 105, no. 4, pp. 515–523, 2002. View at Publisher · View at Google Scholar · View at Scopus
82. S. N. de-Campos, C. Souza-Lemos, A. Teva, R. Porrozzi, and G. Grimaldi, “Systemic and compartmentalised immune responses in a Leishmania braziliensis-macaque model of self-healing cutaneous leishmaniasis,” Veterinary Immunology and Immunopathology, vol. 137, no. 1-2, pp. 149–154, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
83. T. P. Velavan, S. Bechlars, X. Huang, P. G. Kremsner, and J. F.J. Kun, “Novel regulatory SNPs in the promoter region of the TNFRSF18 gene in a gabonese population,” Brazilian Journal of Medical and Biological Research, vol. 44, no. 5, pp. 418–420, 2011. View at Publisher · View at Google Scholar
84. A. Salhi, V. Rodrigues Jr., F. Santoro et al., “Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis,” Journal of Immunology, vol. 180, no. 9, pp. 6139–6148, 2008. View at Scopus
85. A. V. Grant, M. I. Araujo, E. V. Ponte et al., “Polymorphisms in IL10 are associated with total Immunoglobulin E levels and Schistosoma mansoni infection intensity in a Brazilian population,” Genes and Immunity, vol. 12, pp. 46–50, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
86. G. C. Costa, M. O. D. C. Rocha, P. R. Moreira et al., “Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy,” Journal of Infectious Diseases, vol. 199, no. 3, pp. 451–454, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
87. C. Ouma, G. C. Davenport, T. Were et al., “Haplotypes of IL-10 promoter variants are associated with susceptibility to severe malarial anemia and functional changes in IL-10 production,” Human Genetics, vol. 124, no. 5, pp. 515–524, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
88. H. He, A. Isnard, B. Kouriba et al., “A STAT6 gene polymorphism is associated with high infection levels in urinary schistosomiasis,” Genes and Immunity, vol. 9, no. 3, pp. 195–206, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
89. A. Isnard, B. Kouriba, O. Doumbo, and C. Chevillard, “Association of rs7719175, located in the IL13 gene promoter, with Schistosoma haematobium infection levels and identification of a susceptibility haplotype,” Genes and Immunity, vol. 12, pp. 31–39, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus